The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Systemic Anti-Infectives Market Research Report 2025

Global Systemic Anti-Infectives Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1672329

No of Pages : 106

Ask Your Query
Synopsis
Anti-infective drugs are drugs that have the effect of killing or inhibiting the above pathogenic microorganisms and are applied systemically or topically by oral, intramuscular, intravenous or topical application. Systemic anti-infective drugs are the basic drugs and are widely used in the treatment of bacterial, fungal, chlamydial and viral infections and other infectious complications arising from other diseases.
The global Systemic Anti-Infectives market was valued at US$ 15620 million in 2023 and is anticipated to reach US$ 20430 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Systemic Anti-Infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Anti-Infectives.
Report Scope
The Systemic Anti-Infectives market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Systemic Anti-Infectives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Systemic Anti-Infectives companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sumitomo Dainippon Pharma
MSD
Bayer
Bristol-Myers Squibb
Dechra
Alandalous
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Chiatai Tianqing
Hailing Pharm
Southwest Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan
Harbin Pharmaceutical Group
CSPC Pharmaceutical
North China Pharmaceutical
Sinopharm
Luoxin Pharmaceutical
CR Pharma
Duopharma Biotech Group
PT Infion Pharma
Bright-gene
Segment by Type
Injections
Tablets
Capsules & Pellets
Others
Segment by Application
Hospital
Clinic
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Systemic Anti-Infectives companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Anti-Infectives Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injections
1.2.3 Tablets
1.2.4 Capsules & Pellets
1.2.5 Others
1.3 Market by Application
1.3.1 Global Systemic Anti-Infectives Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstores
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Systemic Anti-Infectives Market Perspective (2019-2030)
2.2 Systemic Anti-Infectives Growth Trends by Region
2.2.1 Global Systemic Anti-Infectives Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Systemic Anti-Infectives Historic Market Size by Region (2019-2024)
2.2.3 Systemic Anti-Infectives Forecasted Market Size by Region (2025-2030)
2.3 Systemic Anti-Infectives Market Dynamics
2.3.1 Systemic Anti-Infectives Industry Trends
2.3.2 Systemic Anti-Infectives Market Drivers
2.3.3 Systemic Anti-Infectives Market Challenges
2.3.4 Systemic Anti-Infectives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Anti-Infectives Players by Revenue
3.1.1 Global Top Systemic Anti-Infectives Players by Revenue (2019-2024)
3.1.2 Global Systemic Anti-Infectives Revenue Market Share by Players (2019-2024)
3.2 Global Systemic Anti-Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Systemic Anti-Infectives Revenue
3.4 Global Systemic Anti-Infectives Market Concentration Ratio
3.4.1 Global Systemic Anti-Infectives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Anti-Infectives Revenue in 2023
3.5 Systemic Anti-Infectives Key Players Head office and Area Served
3.6 Key Players Systemic Anti-Infectives Product Solution and Service
3.7 Date of Enter into Systemic Anti-Infectives Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Anti-Infectives Breakdown Data by Type
4.1 Global Systemic Anti-Infectives Historic Market Size by Type (2019-2024)
4.2 Global Systemic Anti-Infectives Forecasted Market Size by Type (2025-2030)
5 Systemic Anti-Infectives Breakdown Data by Application
5.1 Global Systemic Anti-Infectives Historic Market Size by Application (2019-2024)
5.2 Global Systemic Anti-Infectives Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Systemic Anti-Infectives Market Size (2019-2030)
6.2 North America Systemic Anti-Infectives Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Systemic Anti-Infectives Market Size by Country (2019-2024)
6.4 North America Systemic Anti-Infectives Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Systemic Anti-Infectives Market Size (2019-2030)
7.2 Europe Systemic Anti-Infectives Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Systemic Anti-Infectives Market Size by Country (2019-2024)
7.4 Europe Systemic Anti-Infectives Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Systemic Anti-Infectives Market Size (2019-2030)
8.2 Asia-Pacific Systemic Anti-Infectives Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Systemic Anti-Infectives Market Size by Region (2019-2024)
8.4 Asia-Pacific Systemic Anti-Infectives Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Systemic Anti-Infectives Market Size (2019-2030)
9.2 Latin America Systemic Anti-Infectives Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Systemic Anti-Infectives Market Size by Country (2019-2024)
9.4 Latin America Systemic Anti-Infectives Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Anti-Infectives Market Size (2019-2030)
10.2 Middle East & Africa Systemic Anti-Infectives Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Systemic Anti-Infectives Market Size by Country (2019-2024)
10.4 Middle East & Africa Systemic Anti-Infectives Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Systemic Anti-Infectives Introduction
11.1.4 Pfizer Revenue in Systemic Anti-Infectives Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Sumitomo Dainippon Pharma
11.2.1 Sumitomo Dainippon Pharma Company Detail
11.2.2 Sumitomo Dainippon Pharma Business Overview
11.2.3 Sumitomo Dainippon Pharma Systemic Anti-Infectives Introduction
11.2.4 Sumitomo Dainippon Pharma Revenue in Systemic Anti-Infectives Business (2019-2024)
11.2.5 Sumitomo Dainippon Pharma Recent Development
11.3 MSD
11.3.1 MSD Company Detail
11.3.2 MSD Business Overview
11.3.3 MSD Systemic Anti-Infectives Introduction
11.3.4 MSD Revenue in Systemic Anti-Infectives Business (2019-2024)
11.3.5 MSD Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Systemic Anti-Infectives Introduction
11.4.4 Bayer Revenue in Systemic Anti-Infectives Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Systemic Anti-Infectives Introduction
11.5.4 Bristol-Myers Squibb Revenue in Systemic Anti-Infectives Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Dechra
11.6.1 Dechra Company Detail
11.6.2 Dechra Business Overview
11.6.3 Dechra Systemic Anti-Infectives Introduction
11.6.4 Dechra Revenue in Systemic Anti-Infectives Business (2019-2024)
11.6.5 Dechra Recent Development
11.7 Alandalous
11.7.1 Alandalous Company Detail
11.7.2 Alandalous Business Overview
11.7.3 Alandalous Systemic Anti-Infectives Introduction
11.7.4 Alandalous Revenue in Systemic Anti-Infectives Business (2019-2024)
11.7.5 Alandalous Recent Development
11.8 GSK
11.8.1 GSK Company Detail
11.8.2 GSK Business Overview
11.8.3 GSK Systemic Anti-Infectives Introduction
11.8.4 GSK Revenue in Systemic Anti-Infectives Business (2019-2024)
11.8.5 GSK Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Systemic Anti-Infectives Introduction
11.9.4 Teva Revenue in Systemic Anti-Infectives Business (2019-2024)
11.9.5 Teva Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Systemic Anti-Infectives Introduction
11.10.4 Johnson & Johnson Revenue in Systemic Anti-Infectives Business (2019-2024)
11.10.5 Johnson & Johnson Recent Development
11.11 NOVARTIS
11.11.1 NOVARTIS Company Detail
11.11.2 NOVARTIS Business Overview
11.11.3 NOVARTIS Systemic Anti-Infectives Introduction
11.11.4 NOVARTIS Revenue in Systemic Anti-Infectives Business (2019-2024)
11.11.5 NOVARTIS Recent Development
11.12 MYLAN
11.12.1 MYLAN Company Detail
11.12.2 MYLAN Business Overview
11.12.3 MYLAN Systemic Anti-Infectives Introduction
11.12.4 MYLAN Revenue in Systemic Anti-Infectives Business (2019-2024)
11.12.5 MYLAN Recent Development
11.13 Sun Pharma
11.13.1 Sun Pharma Company Detail
11.13.2 Sun Pharma Business Overview
11.13.3 Sun Pharma Systemic Anti-Infectives Introduction
11.13.4 Sun Pharma Revenue in Systemic Anti-Infectives Business (2019-2024)
11.13.5 Sun Pharma Recent Development
11.14 CR SANJIU
11.14.1 CR SANJIU Company Detail
11.14.2 CR SANJIU Business Overview
11.14.3 CR SANJIU Systemic Anti-Infectives Introduction
11.14.4 CR SANJIU Revenue in Systemic Anti-Infectives Business (2019-2024)
11.14.5 CR SANJIU Recent Development
11.15 Cipla
11.15.1 Cipla Company Detail
11.15.2 Cipla Business Overview
11.15.3 Cipla Systemic Anti-Infectives Introduction
11.15.4 Cipla Revenue in Systemic Anti-Infectives Business (2019-2024)
11.15.5 Cipla Recent Development
11.16 Chiatai Tianqing
11.16.1 Chiatai Tianqing Company Detail
11.16.2 Chiatai Tianqing Business Overview
11.16.3 Chiatai Tianqing Systemic Anti-Infectives Introduction
11.16.4 Chiatai Tianqing Revenue in Systemic Anti-Infectives Business (2019-2024)
11.16.5 Chiatai Tianqing Recent Development
11.17 Hailing Pharm
11.17.1 Hailing Pharm Company Detail
11.17.2 Hailing Pharm Business Overview
11.17.3 Hailing Pharm Systemic Anti-Infectives Introduction
11.17.4 Hailing Pharm Revenue in Systemic Anti-Infectives Business (2019-2024)
11.17.5 Hailing Pharm Recent Development
11.18 Southwest Pharmaceutical Co., Ltd.
11.18.1 Southwest Pharmaceutical Co., Ltd. Company Detail
11.18.2 Southwest Pharmaceutical Co., Ltd. Business Overview
11.18.3 Southwest Pharmaceutical Co., Ltd. Systemic Anti-Infectives Introduction
11.18.4 Southwest Pharmaceutical Co., Ltd. Revenue in Systemic Anti-Infectives Business (2019-2024)
11.18.5 Southwest Pharmaceutical Co., Ltd. Recent Development
11.19 Guangzhou Baiyunshan
11.19.1 Guangzhou Baiyunshan Company Detail
11.19.2 Guangzhou Baiyunshan Business Overview
11.19.3 Guangzhou Baiyunshan Systemic Anti-Infectives Introduction
11.19.4 Guangzhou Baiyunshan Revenue in Systemic Anti-Infectives Business (2019-2024)
11.19.5 Guangzhou Baiyunshan Recent Development
11.20 Harbin Pharmaceutical Group
11.20.1 Harbin Pharmaceutical Group Company Detail
11.20.2 Harbin Pharmaceutical Group Business Overview
11.20.3 Harbin Pharmaceutical Group Systemic Anti-Infectives Introduction
11.20.4 Harbin Pharmaceutical Group Revenue in Systemic Anti-Infectives Business (2019-2024)
11.20.5 Harbin Pharmaceutical Group Recent Development
11.21 CSPC Pharmaceutical
11.21.1 CSPC Pharmaceutical Company Detail
11.21.2 CSPC Pharmaceutical Business Overview
11.21.3 CSPC Pharmaceutical Systemic Anti-Infectives Introduction
11.21.4 CSPC Pharmaceutical Revenue in Systemic Anti-Infectives Business (2019-2024)
11.21.5 CSPC Pharmaceutical Recent Development
11.22 North China Pharmaceutical
11.22.1 North China Pharmaceutical Company Detail
11.22.2 North China Pharmaceutical Business Overview
11.22.3 North China Pharmaceutical Systemic Anti-Infectives Introduction
11.22.4 North China Pharmaceutical Revenue in Systemic Anti-Infectives Business (2019-2024)
11.22.5 North China Pharmaceutical Recent Development
11.23 Sinopharm
11.23.1 Sinopharm Company Detail
11.23.2 Sinopharm Business Overview
11.23.3 Sinopharm Systemic Anti-Infectives Introduction
11.23.4 Sinopharm Revenue in Systemic Anti-Infectives Business (2019-2024)
11.23.5 Sinopharm Recent Development
11.24 Luoxin Pharmaceutical
11.24.1 Luoxin Pharmaceutical Company Detail
11.24.2 Luoxin Pharmaceutical Business Overview
11.24.3 Luoxin Pharmaceutical Systemic Anti-Infectives Introduction
11.24.4 Luoxin Pharmaceutical Revenue in Systemic Anti-Infectives Business (2019-2024)
11.24.5 Luoxin Pharmaceutical Recent Development
11.25 CR Pharma
11.25.1 CR Pharma Company Detail
11.25.2 CR Pharma Business Overview
11.25.3 CR Pharma Systemic Anti-Infectives Introduction
11.25.4 CR Pharma Revenue in Systemic Anti-Infectives Business (2019-2024)
11.25.5 CR Pharma Recent Development
11.26 Duopharma Biotech Group
11.26.1 Duopharma Biotech Group Company Detail
11.26.2 Duopharma Biotech Group Business Overview
11.26.3 Duopharma Biotech Group Systemic Anti-Infectives Introduction
11.26.4 Duopharma Biotech Group Revenue in Systemic Anti-Infectives Business (2019-2024)
11.26.5 Duopharma Biotech Group Recent Development
11.27 PT Infion Pharma
11.27.1 PT Infion Pharma Company Detail
11.27.2 PT Infion Pharma Business Overview
11.27.3 PT Infion Pharma Systemic Anti-Infectives Introduction
11.27.4 PT Infion Pharma Revenue in Systemic Anti-Infectives Business (2019-2024)
11.27.5 PT Infion Pharma Recent Development
11.28 Bright-gene
11.28.1 Bright-gene Company Detail
11.28.2 Bright-gene Business Overview
11.28.3 Bright-gene Systemic Anti-Infectives Introduction
11.28.4 Bright-gene Revenue in Systemic Anti-Infectives Business (2019-2024)
11.28.5 Bright-gene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Systemic Anti-Infectives Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injections
Table 3. Key Players of Tablets
Table 4. Key Players of Capsules & Pellets
Table 5. Key Players of Others
Table 6. Global Systemic Anti-Infectives Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Systemic Anti-Infectives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Systemic Anti-Infectives Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Systemic Anti-Infectives Market Share by Region (2019-2024)
Table 10. Global Systemic Anti-Infectives Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Systemic Anti-Infectives Market Share by Region (2025-2030)
Table 12. Systemic Anti-Infectives Market Trends
Table 13. Systemic Anti-Infectives Market Drivers
Table 14. Systemic Anti-Infectives Market Challenges
Table 15. Systemic Anti-Infectives Market Restraints
Table 16. Global Systemic Anti-Infectives Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Systemic Anti-Infectives Market Share by Players (2019-2024)
Table 18. Global Top Systemic Anti-Infectives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Anti-Infectives as of 2023)
Table 19. Ranking of Global Top Systemic Anti-Infectives Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Systemic Anti-Infectives Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Systemic Anti-Infectives Product Solution and Service
Table 23. Date of Enter into Systemic Anti-Infectives Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Systemic Anti-Infectives Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Systemic Anti-Infectives Revenue Market Share by Type (2019-2024)
Table 27. Global Systemic Anti-Infectives Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Systemic Anti-Infectives Revenue Market Share by Type (2025-2030)
Table 29. Global Systemic Anti-Infectives Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Systemic Anti-Infectives Revenue Market Share by Application (2019-2024)
Table 31. Global Systemic Anti-Infectives Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Systemic Anti-Infectives Revenue Market Share by Application (2025-2030)
Table 33. North America Systemic Anti-Infectives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Systemic Anti-Infectives Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Systemic Anti-Infectives Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Systemic Anti-Infectives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Systemic Anti-Infectives Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Systemic Anti-Infectives Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Systemic Anti-Infectives Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Systemic Anti-Infectives Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Systemic Anti-Infectives Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Systemic Anti-Infectives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Systemic Anti-Infectives Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Systemic Anti-Infectives Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Systemic Anti-Infectives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Systemic Anti-Infectives Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Systemic Anti-Infectives Market Size by Country (2025-2030) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Systemic Anti-Infectives Product
Table 51. Pfizer Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Sumitomo Dainippon Pharma Company Detail
Table 54. Sumitomo Dainippon Pharma Business Overview
Table 55. Sumitomo Dainippon Pharma Systemic Anti-Infectives Product
Table 56. Sumitomo Dainippon Pharma Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 57. Sumitomo Dainippon Pharma Recent Development
Table 58. MSD Company Detail
Table 59. MSD Business Overview
Table 60. MSD Systemic Anti-Infectives Product
Table 61. MSD Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 62. MSD Recent Development
Table 63. Bayer Company Detail
Table 64. Bayer Business Overview
Table 65. Bayer Systemic Anti-Infectives Product
Table 66. Bayer Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Bristol-Myers Squibb Company Detail
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Systemic Anti-Infectives Product
Table 71. Bristol-Myers Squibb Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Dechra Company Detail
Table 74. Dechra Business Overview
Table 75. Dechra Systemic Anti-Infectives Product
Table 76. Dechra Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 77. Dechra Recent Development
Table 78. Alandalous Company Detail
Table 79. Alandalous Business Overview
Table 80. Alandalous Systemic Anti-Infectives Product
Table 81. Alandalous Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 82. Alandalous Recent Development
Table 83. GSK Company Detail
Table 84. GSK Business Overview
Table 85. GSK Systemic Anti-Infectives Product
Table 86. GSK Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 87. GSK Recent Development
Table 88. Teva Company Detail
Table 89. Teva Business Overview
Table 90. Teva Systemic Anti-Infectives Product
Table 91. Teva Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 92. Teva Recent Development
Table 93. Johnson & Johnson Company Detail
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Systemic Anti-Infectives Product
Table 96. Johnson & Johnson Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 97. Johnson & Johnson Recent Development
Table 98. NOVARTIS Company Detail
Table 99. NOVARTIS Business Overview
Table 100. NOVARTIS Systemic Anti-Infectives Product
Table 101. NOVARTIS Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 102. NOVARTIS Recent Development
Table 103. MYLAN Company Detail
Table 104. MYLAN Business Overview
Table 105. MYLAN Systemic Anti-Infectives Product
Table 106. MYLAN Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 107. MYLAN Recent Development
Table 108. Sun Pharma Company Detail
Table 109. Sun Pharma Business Overview
Table 110. Sun Pharma Systemic Anti-Infectives Product
Table 111. Sun Pharma Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 112. Sun Pharma Recent Development
Table 113. CR SANJIU Company Detail
Table 114. CR SANJIU Business Overview
Table 115. CR SANJIU Systemic Anti-Infectives Product
Table 116. CR SANJIU Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 117. CR SANJIU Recent Development
Table 118. Cipla Company Detail
Table 119. Cipla Business Overview
Table 120. Cipla Systemic Anti-Infectives Product
Table 121. Cipla Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 122. Cipla Recent Development
Table 123. Chiatai Tianqing Company Detail
Table 124. Chiatai Tianqing Business Overview
Table 125. Chiatai Tianqing Systemic Anti-Infectives Product
Table 126. Chiatai Tianqing Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 127. Chiatai Tianqing Recent Development
Table 128. Hailing Pharm Company Detail
Table 129. Hailing Pharm Business Overview
Table 130. Hailing Pharm Systemic Anti-Infectives Product
Table 131. Hailing Pharm Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 132. Hailing Pharm Recent Development
Table 133. Southwest Pharmaceutical Co., Ltd. Company Detail
Table 134. Southwest Pharmaceutical Co., Ltd. Business Overview
Table 135. Southwest Pharmaceutical Co., Ltd. Systemic Anti-Infectives Product
Table 136. Southwest Pharmaceutical Co., Ltd. Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 137. Southwest Pharmaceutical Co., Ltd. Recent Development
Table 138. Guangzhou Baiyunshan Company Detail
Table 139. Guangzhou Baiyunshan Business Overview
Table 140. Guangzhou Baiyunshan Systemic Anti-Infectives Product
Table 141. Guangzhou Baiyunshan Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 142. Guangzhou Baiyunshan Recent Development
Table 143. Harbin Pharmaceutical Group Company Detail
Table 144. Harbin Pharmaceutical Group Business Overview
Table 145. Harbin Pharmaceutical Group Systemic Anti-Infectives Product
Table 146. Harbin Pharmaceutical Group Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 147. Harbin Pharmaceutical Group Recent Development
Table 148. CSPC Pharmaceutical Company Detail
Table 149. CSPC Pharmaceutical Business Overview
Table 150. CSPC Pharmaceutical Systemic Anti-Infectives Product
Table 151. CSPC Pharmaceutical Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 152. CSPC Pharmaceutical Recent Development
Table 153. North China Pharmaceutical Company Detail
Table 154. North China Pharmaceutical Business Overview
Table 155. North China Pharmaceutical Systemic Anti-Infectives Product
Table 156. North China Pharmaceutical Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 157. North China Pharmaceutical Recent Development
Table 158. Sinopharm Company Detail
Table 159. Sinopharm Business Overview
Table 160. Sinopharm Systemic Anti-Infectives Product
Table 161. Sinopharm Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 162. Sinopharm Recent Development
Table 163. Luoxin Pharmaceutical Company Detail
Table 164. Luoxin Pharmaceutical Business Overview
Table 165. Luoxin Pharmaceutical Systemic Anti-Infectives Product
Table 166. Luoxin Pharmaceutical Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 167. Luoxin Pharmaceutical Recent Development
Table 168. CR Pharma Company Detail
Table 169. CR Pharma Business Overview
Table 170. CR Pharma Systemic Anti-Infectives Product
Table 171. CR Pharma Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 172. CR Pharma Recent Development
Table 173. Duopharma Biotech Group Company Detail
Table 174. Duopharma Biotech Group Business Overview
Table 175. Duopharma Biotech Group Systemic Anti-Infectives Product
Table 176. Duopharma Biotech Group Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 177. Duopharma Biotech Group Recent Development
Table 178. PT Infion Pharma Company Detail
Table 179. PT Infion Pharma Business Overview
Table 180. PT Infion Pharma Systemic Anti-Infectives Product
Table 181. PT Infion Pharma Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 182. PT Infion Pharma Recent Development
Table 183. Bright-gene Company Detail
Table 184. Bright-gene Business Overview
Table 185. Bright-gene Systemic Anti-Infectives Product
Table 186. Bright-gene Revenue in Systemic Anti-Infectives Business (2019-2024) & (US$ Million)
Table 187. Bright-gene Recent Development
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Anti-Infectives Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Systemic Anti-Infectives Market Share by Type: 2023 VS 2030
Figure 3. Injections Features
Figure 4. Tablets Features
Figure 5. Capsules & Pellets Features
Figure 6. Others Features
Figure 7. Global Systemic Anti-Infectives Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Systemic Anti-Infectives Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Drugstores Case Studies
Figure 12. Others Case Studies
Figure 13. Systemic Anti-Infectives Report Years Considered
Figure 14. Global Systemic Anti-Infectives Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Systemic Anti-Infectives Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Systemic Anti-Infectives Market Share by Region: 2023 VS 2030
Figure 17. Global Systemic Anti-Infectives Market Share by Players in 2023
Figure 18. Global Top Systemic Anti-Infectives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Anti-Infectives as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Systemic Anti-Infectives Revenue in 2023
Figure 20. North America Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Systemic Anti-Infectives Market Share by Country (2019-2030)
Figure 22. United States Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Systemic Anti-Infectives Market Share by Country (2019-2030)
Figure 26. Germany Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Systemic Anti-Infectives Market Share by Region (2019-2030)
Figure 34. China Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Systemic Anti-Infectives Market Share by Country (2019-2030)
Figure 42. Mexico Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Systemic Anti-Infectives Market Share by Country (2019-2030)
Figure 46. Turkey Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Systemic Anti-Infectives Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 49. Sumitomo Dainippon Pharma Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 50. MSD Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 51. Bayer Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 53. Dechra Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 54. Alandalous Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 55. GSK Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 56. Teva Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 57. Johnson & Johnson Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 58. NOVARTIS Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 59. MYLAN Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 60. Sun Pharma Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 61. CR SANJIU Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 62. Cipla Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 63. Chiatai Tianqing Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 64. Hailing Pharm Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 65. Southwest Pharmaceutical Co., Ltd. Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 66. Guangzhou Baiyunshan Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 67. Harbin Pharmaceutical Group Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 68. CSPC Pharmaceutical Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 69. North China Pharmaceutical Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 70. Sinopharm Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 71. Luoxin Pharmaceutical Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 72. CR Pharma Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 73. Duopharma Biotech Group Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 74. PT Infion Pharma Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 75. Bright-gene Revenue Growth Rate in Systemic Anti-Infectives Business (2019-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock